News Feature

An overview of the not-so-distant past, and an outlook for the not-so-distant future

A national treasure in three temporary trailers

Stem cell banking must expand to keep up with demand, say researchers

If stem cell therapies are going to succeed in the clinic, researchers must determine the safest and most efficient ways to transplant cells into the body.

Why stem-cell therapy could start with the eyes

Finding the right way to protect cells, and intellectual property, will be key for getting cell therapy to patients

Analyses of individual stem cells are gaining momentum, but technological barriers persist

Some think the US should adopt a UK regulatory structure for embryo research

The US president's executive order does not spell the end to the problems facing ES cell research

In a field rife with dissension, four recent papers may resolve one of the haematopoietic community's greatest disputes

Mathematics can turn experimental data into information, if the personality fits

The promise of stem cells in reconstructive surgery has prompted a surge in rejuvenating skin creams that claim to stimulate them. But commercial success says nothing about efficacy

A biotech start-up sees stem cells as targets, not transplants

Does stem cell therapy contain too many unknowns to move into human clinical trials?

Tumour cells that can initiate a new tumour are not so rare as previously thought, putting the concept of the 'cancer stem cell' under the spotlight again.

A new programme at the US Department of Defense funds regenerative medicine to help wounded vets, but a surprising level of detail seems top secret

Stem cell researchers say that favourable policy in the United Kingdom is the result of taking the time to win over legislators

Some bioethicists see history repeating itself

A new quest for short cuts between specialized states could lay bare the machinery governing cell fate

Worries that the NIH did not properly evaluate informed consent by donors of embryos from which stem cell lines were derived throw oversight committees into disarray